Nutritional Agents : Replenishers & Regulators of Water & Electrolytes
OFOSR1 “Fosrenol tablet” 750mg
適應症：適用於正在進行血液透析或連續性腹膜透析(CAPD)的慢性腎衰竭病人之高磷酸鹽血症的第二線治療。
Usual dose:
Adult:
End stage renal disease – Hyperphosphatemia: initial, 1500 mg PO per day in divided doses with meals, then titrate in increments of 750 mg/day at intervals of 2-3 weeks.
End stage renal disease – Hyperphosphatemia: maintenance, 1500-3000 mg PO qd in divided doses with meals.
Adverse effect:
Common: Abdominal pain, Nausea, Vomiting.
Serious: Vascular graft occlusion, Dialysis, Bowel obstruction, Fecal impaction, Gastrointestinal obstruction.
Related Entries
(Visited 25 times, 1 visits today)